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1. Introduction 
End-stage renal disease (ESRD) is a severe  health problem with  high mortality and 
morbidity rates and growing incidence worldwide. Recently, two main renal replacement 
therapy modalities have been used for ESRD patients: Dialysis and kidney transplantation. 
It is undoubtedly clear that transplantation is the best choise for long term survival and 
every transplantation candidate is also a preemptive transplantation candidate. 
Preemptive kidney transplantation(PKT) may be summarized as transplantation before the 
commencement of dialysis in ESRD patients. Preemptive transplantation confers a 
significant benefit in terms of both patient and allograft survival. The benefit thought to be 
the result of avoidence of cardiovascular adverse effects of long term dialysis. Current 
opinion allows ESRD patients to receive PKT when their GFR is 20 mL per minute or less 
and preparation for transplantation should be started at the time of the diagnosing chronic 
renal disease.  
Kidney transplantation should be the choise of therapy in ESRD patients not only because of 
improving graft and patient survival and also preventing dialysis related comorbidities and 
lower cost in the long term(1,2,3). New and more effective immunsupressive drugs, growing 
experience in transplantation surgery are making kidney transplantation a more common 
and safe option. 
Although there are studies showing nephrologists have the same opinion that preemptive 
transplantation is the best treatment modality for eligible ESRD patients, that has been 
convincingly shown to improve posttransplant graft and patient survival. Unfortunately, 
while PKT is much more beneficial over transplantation, preemptive kidney transplantation 
seems to be underutilized specially as a result of late referral of the patients to a 
nephrologist and transplantation center. Only 2% of ESRD patients receive PKT while one 
forth of transplantation procedures are preemptive in children in the USA. Of course, there 
are other difficulties for PKT such as poor health status, lack of compliance, comorbidities, 
older patients, longer waiting time for deceased kidney donors and lack of social insurance.  
Ideally, preparation for transplantation should be initiated as soon as progressive chronic 
kidney disease (CKD) is recognized because cardiovascular morbidity and mortality rates 
increases while CKD progresses. Early referral to a nephrologist has a vital importance in 
this situation. Unfortunately, just about 50% of CKD patients come upon a nephrologist in 
end stage of chronic renal disease. Early referral not only allows careful preparation for PKT 
and also evaluation of potential living donor candidates and selecting the exact time for 
transplantation. Because the course of CKD varies according to the primary disease, earliest 
referral is synonymous to early preparation and beter outcome for transplantation. 
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GFR 20 mL per minute or less is widely accepted to be the time for preemptive kidney 
transplantation regardless of the etiology of the kidney disease. Diabetic CKD patients 
should also be evaluated for pancreatic islet cell transplantation. Kidney biopsy may be 
helpful for potentially recurring primary kidney diseases after transplantation. A living 
kidney donor enhances the chance for PKT but deceased kidney donor may be an 
alternative that should not be failed to remember and all patients should be added to 
waiting list when GFR decreases under 20 mL per minute. Previously transplantated 
patients may also be candidates for another PKT. 
Recent studies show that preemptive transplantation has better outcomes than non-
preemptive transplantation. Lower infection, lower hypertension and less acute rejection 
episode rates in preemptive transplant patients may be the main reasons for these results. 
PKT allows preventing from complications during hemodialysis, higher hemoglobin levels 
before transplantation, lower cardiovascular disease and coronary artery calcification rates, 
better consistency to immunsuppressive therapy and beter life-quality. Long term graft and 
patient survival are two major motivators for PKT. 
Although kidney transplantation has many advantages against other therapeutic 
approaches, has its own problems. While kidney transplantation becomes more prevalent, 
post transplant problems growing as well and transplant recipients becomes a “special 
patient group”. Minimazing the problems of this “special patient group” is a significant 
target and may only be achieved by proper choise of recipients, appropriate preparation and 
finally exact timing of transplantation. 
Is preemptive kidney transplantation exact time of transplantation? Until mid 80’s 
preemptive transplantation has been thought to have worse results than non preemptive 
(4,5). But after 90’s more recent studies referred just the opposite (6,7). Currently, the 
question stil remains controversial for nephrologists. 
Both in Turkey and in the world, widening of transplantation centers and experienced 
surgeons and nephrologists PKT has become a more common option. Specially in stage 3 
and stage 4 CKD patients early referral to a transplantation center carries a high importance 
for long term survival.  
In USA, PKT constitude 25% of living donor transplantations and 10% of deceased donor 
transplantations, while the rates are 34% and 14% for chidren recipients respectively(8,9). 
PKT in children has beter percentages because of family relationships, easier to find a donor 
for children and probably more doubt of adult nephrologist for PKT (10). 
PKT offers preventing dialysis related co-morbidities. Approximately 20% of hemodialysis 
patients have been hospitalized for vascular access problems and 50% has cateter infections 
per year. In addition prolonging of hemodialysis process results irreversible cardiovascular 
problem even after transplantation (7,11). PKT has beter outcomes for both post transplant 
graft and patient survival and also co-morbidities happening during a dialysis period 
(10,11). 
Mange et al showed improved graft survival of PKT in 8481 living donor transplantation 
with 52% decrease for graft loss for  PKT over non preemptive (12). Kasiske et al found 
similar results for both living and deceased donor transplantation(13). Chronic allograft 
nephropathy rates are lower for PKT (14). Some investigators suggest that improved graft 
survival in PKT patients is a natural result of beter patient survival of selected patients for 
PKT. Besides other factors for graft survival are similar (15).  
It is clear that prolongation of dialysis period in non-preemptive transplantation may result 
irreversible complications such as cardiovascular disease, renal allograft vascular disease, 
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malnutrition, chronic inlammation,impaired immunologic functions and inadequate 
clearence in ESRD patients (16,17). Immun system impairment may cause unavoidable 
infections during dialysis period (18,19,20). Non-preemptive transplantation patients expose 
to dialysis membranes that may cause activations in immun system which may even cause 
acute rejection (21,22,23). Hypertensionand left ventricular hypertrophy are more common 
in nonpreemptive group because of the interdialytic weight gain.  
Kidney transplantation should be the first choise in ESRD patients. PKT may be termed as 
créme de la créme  and should never be underestimated. Preparation for transplantation 
should be initiated at the time CKD has been diagnosed and every CKD patient should be 
accepted as a candidate for PKT for better survival and life-quality. 
2. Results and offers 
Every CRD patient is a candidate for PKT. 
PKT is an important alternative to avoid from dialysis related co-morbidities and 
complications. 
PKT has improved graft and patient survival rates over non preemptive KT. 
Early referral to a transplantation center allows  proper choise of recipients, appropriate 
preparation and finally exact timing of transplantation. 
PKT offers lower infection rates, lower cardiovascular disease and better life quality. 
Every transplantation candidate is also a preemptive transplantation candidate. 
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